ReviewWorld journal of microbiology & biotechnology2026
Protein engineering and high-throughput screening of lytic polysaccharide monooxygenases: strategies, challenges, and prospects for industrial applications.
Review in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Lytic polysaccharide monooxygenases (LPMOs) are a class of copper-dependent oxidases capable of cleaving glycosidic bonds in crystalline polysaccharides through oxidative mechanisms, playing a pivotal role in biomass refining and green biomanufacturing. However, natural LPMOs still face technical bottlenecks such as insufficient electron transfer efficiency, limited catalytic activity, and poor stability under industrial reaction conditions. This review systematically summarizes the classification, structure, catalytic mechanisms, and diverse applications of LPMOs. It focuses on analyzing research progress in modifying LPMOs through protein engineering strategies such as rational design (e.g., disulfide bond engineering, active site optimization) and directed evolution. Furthermore, it summarizes current high-throughput technologies suitable for LPMO mutant screening. Finally, it outlines future development directions including AI-assisted design and cell-free expression systems, providing references for further enzyme engineering and industrial applications.
Indexed as
Identifiers
42105045What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.